Article ID Journal Published Year Pages File Type
5537160 Vaccine 2017 7 Pages PDF
Abstract
The data from this 20-year follow-up study confirm previous observations that two doses of Epaxal® provide protection against hepatitis A infection for at least 30 years in over 95% of healthy participants.
Keywords
Related Topics
Life Sciences Immunology and Microbiology Immunology
Preview
Immunogenicity and estimation of antibody persistence following vaccination with an inactivated virosomal hepatitis A vaccine in adults: A 20-year follow-up study
Authors
, , , , , , ,